Shu Man Fu, Deshmukh US, Gaskin F. Pathogenesis of systemic lupus erythematosus revisited 2011: end organ resistance to damage, autoantibody initiation and diversification, and HLA-DR. J Autoimmune 2011; 37(2): 104-112. doi: 10.1016/j.jaut.2011.05.004.
Namazi S, Ziaee V, Rezaei N. The role of cytokines in systemic lupus erythematosis: review article. Tehran Univ Medical J 2015; 73(6): 397- 404.
Lisnevskaia L, Murphy G, Isenberg D. Systemic lupus erythematosus. Lancet 2014; 384 (9957): 1878-88. doi: 10.1016/s0140-6736(14)60128- 8.
Tobón GJ, Izquierdo JH, Cañas CA. B lymphocytes: development, tolerance, and their role in autoimmunity-focus on systemic lupus erythematosus. Autoimmune Dis 2013; 2013:827254. doi: 10.1155/2013/827254
Ahearn MJ, Liu C, Kao HA, Manzi
S. Biomarkers for systemic lupus erythematosus. Transi Res 2012; 159: 326-342. doi: 10.1016/j.trsl.2012.01.021.
Rottman JB, Willis CR. Mouse models of systemic lupus erythematosus reveal a complex pathogenesis. Vet Pathol 2010; 47(4):664-76. doi: 10.1177/ 0300985810370005.
Liu Y, Yin H, Zhao M, Lu Q. TLR2 and TLR4 in Autoimmune Diseases: a Comprehensive Review. Clin Rev Allergy Immunol 2014; 47(2): 136- 47. doi: 10.1007/s12016-013-8402-y.
Rullo OJ, Tsao BP. Recent insights into the genetic basis of systemic lupus erythematosus. Ann Rheum Dis 2013; 72 Suppl 2: ii56-61. doi: 10.1136/annrheumdis-2012-202351.
Darrah E, Andrade F. NETs: the missing link between cell death and systemic autoimmune diseases? Front Immunol 2013; 3: 428. doi: 10.3389/fimmu.2012.00428.
Aringer M, Günther C, Lee-Kirsch
MA. Innate immune processes in lupus erythematosus. Clin Immunol 2013; 147(3): 216-222. doi: 10.1016/j.clim.2012.11.012.
Lewis J.E, Man Fu Sand Gaskin F. Autoimmunity, End Organ Damage and the Origin of Autoantibodies and Autoreactive T Cells in Systemic Lupus Erythematosus. Discov Med 2013; 15(81): 85-92.
Shrivastav M and Niewold T.B. Nucleicacid sensors and type I interferon production in systemic lupus erythematosus. Frontier in Immunology 2013; 4(319): 1-10. doi: 10.3389/fimmu.2013.00319.
Fortuna G, Brennan M.T. Systemic Lupus Erythematosus: Epidemiology, Pathophysiology, Manifestations, and Management. Dent Clin N Am 2013; 57: 631-655. doi: 10.1016/j.cden. 2013.06.003.
Conti G, Coppo R and Amore A. Pathogenesis of systemic lupus erythematosus (LES). G Ital Nefrol 2012; 29:84-90.
Chan VS, Nie YJ, Shen N, Yan S, Mok MY, Lau CS. Distinct roles of myeloid and plasmacytoid dendritic cells in systemic lupus erythematosus. Autoimmun Rev 2012; 11(12): 890-897. doi: 10.1016/ j.autrev.2012.03.004.
Choi J, Kim ST, Craft J. The pathogenesis of systemic lupus erythematosus-an update. Curr Opin Immunol 2012; 24(6): 651-657. doi: 10.1016/j.coi.2012.10.004.
Sturfelt G, Truedsson L. Complement in the immunopathogenesis of rheumatic diseas. Nat Rev Rheumatol 2012; 8: 458-468. doi: 10.1038/nrrheum.2012.75.
Tsokos GC. Mechanisms of Disease Systemic Lupus Erythematosus. N Engl J Med 2011; 365: 2110-2121. doi: 10.1056/NEJMra1100359.
Mak A, Tay SH. Environmental factors, toxicants and systemic lupus erythematosus. Int J Mol Sci 2014; 15(9):16043-56. doi: 10.3390/ ijms150916043.
Bertsias G, Cervera R, Boumpas DT. Systemic Lupus Erythematosus: Pathogenesis and Clinical Features. In: Wilhelmus J, Bijlsma J (eds). EULAR Textbook on Rheumatic Diseases. BMJ. 2012; 476-505.
Mok CC, Lau CS. Pathogenesis of systemic lupus erythematosus. J Clin Pathol 2003; 56:481-490.
Wahren-Herlenius M, Dörner T. Immunopathogenic mechanisms of systemic autoimmune disease. Lancet 2013; 382(9894): 819-31. doi: 10.1177/0961203311426568.
Tandrup Nielsen Ch. Circulating Microparticles in Systemic Lupus Erythematosus. Dan Med J 2012; 59(11): 1-34. doi: 10.1016/S0140- 6736(13)60954-X.
Zandman-Goddard G, Solomon M, Rosman Z, Peeva E, Shoenfeld Y. Environment and lupus-related diseases. Lupus 2012; 21(3): 241- 250.
Cooper GS, Dooley MA, Treadwell EL, St Clair EW, Gilkeson GS. Smoking and use of hair treatments in relation to risk of developing systemic lupus erythematosus. J Rheumatol 2001; 28: 2653-2656.
Cooper G, Gilbert K, Greidinger E, James J, Pfau J, Reinlib L, Richardson B and Rose N. Recent advances and opportunities in research on lupus: environmental influences and mechanisms of disease. Cien Saude Colet 2009;
14(5): 1865-76.
Pisetsky DS. The immunopathogenesis and immunopathology of systemic lupus erythematosus. In: Schur P.H, Massarotti E.M. Lupus erythematosus: clinical evaluation and treatment. New York: Springer, 2012; 13-26.
Su D.L, Lu Z.M, Shen M.N, Li X, Sun L.Y. Roles of pro- and anti-inflammatory cytokines in the pathogenesis of SLE. J Biomed Biotechnol 2012; 347141: 1-15. doi: 10.1155/2012/347141.
Lee H.M, Sugino H, Nishimoto N. Cytokine networks in systemic lupus erythematosus. J Biomed Biotechnol 2010; 676284: 1-5. doi: 10.1155/ 2010/676284.
Hin Yap DY, Lai KN. The role of cytokines in the pathogenesis of systemic lupus erythematosus– from bench to bedside. Nephrology 2013; 18: 243-255. doi: 10.1111/nep.12047.
Apostolidis S.A, Lieberman L.A, Kis-Toth K, Crispin J.C, Tsokos G.C. The dysregulation of cytokine networks in systemic lupus erythematosus. J Interf Cytok Res 2011; 31(10): 769-779. doi: 10.1089/jir.2011.0029.
Davis L.S, Hutcheson J, Mohan C. The Role of Cytokines in the Pathogenesis and Treatment of Systemic Lupus Erythematosus. J Interf Cytok Res 2011; 31(10): 781- 789. doi: 10.1089/jir.2011.0047.
Ronnblom L, Elkon K.B. Cytokines as therapeutic targets in SLE. Nat Rev Rheumatol 2010; 6:339-347. doi: 10.1038/nrrheum.2010.64.
Perl A. Systems biology of lupus: Mapping the impact of genomic and environmental factors on gene expression signatures, cellular signaling, metabolic pathways, hormonal and cytokine imbalance, and selecting targets for treatment. Autoimmunity 2010; 43(1): 32-47. doi: 10.3109/08916930903374774.
Scholz JL, Oropallo MA, Sindhava V, Goenka R, Cancro MP. The role of B lymphocyte stimulator in B cell biology: implications for the treatment of lupus. Lupus 2013; 22(4): 350-360. doi: 10.1177/ 0961203312469453.
Vincent FB, Saulep-Easton D, Figgett WA, Fairfax KA, Mackay F. The BAFF/APRIL system: Emerging functions beyond B cell biology and autoimmunity. Cytokine & Growth
Factor Reviews 2013; 24: 203-215. doi: 10.1016/j.cytogfr.2013.04.003.
Karageorgas TP, Tseronis DD, Mavragani CP. Activation of Type I Interferon Pathway in Systemic Lupus Erythematosus: Association with Distinct Clinical Phenotypes. J Biomed Biotechnol 2011; 273907:1- 14. doi: 10.1155/2011/273907.
Vincent FB, Morand EF, Schneider P, Mackay F. The BAFF/APRIL system in SLE pathogenesis. Nat Rev Rheumatol 2014; 10(6):365-73. doi: 10.1038/nrrheum.2014.33.
Boghdadi G1, Elewa EA. Increased serum APRIL differentially correlates with distinct cytokine profiles and disease activity in systemic lupus erythematosus patients. Rheumatol Int 2014; 34(9): 1217-23. doi: 10.1007/s00296-014-3020-4.
Eilertsen GO, Nossent JC. APRIL levels strongly correlate with IL-17 in systemic lupus erythematosus. Lupus 2014; 23(13): 1383-91. doi: 10.1177/0961203314543914.
Connolly JJ, Hakonarson H. Role of Cytokines in Systemic Lupus Erythematous: Recent Progress from GWAS and Sequencing. J Biomed Biotechnol 2012; 798924: 1-18. doi: 10.1155/2012/798924.
Postal M, Appenzeller S. The role of Tumor Necrosis Factor-alpha (TNF- α) in the pathogenesis of systemic lupus erythematosus. Cytokine 2011; 56(3): 537-543. doi: 10.1016/j.cyto. 2011.08.026.
Ziaee V, Tahghighi F, Moradinejad MH, Harsini S, Mahmoudi M, Rezaei A, Soltani S, Sadr M, Aghighi Y, Rezaei N. Interleukin-6, interleukin-1 gene cluster and interleukin-1 receptor polymorphisms in Iranian patients with juvenile systemic lupus erythematosus. Eur Cytokine Netw 2014; 25(2): 35-40. doi: 10.1684/ecn. 2014.0352.
Ronnblom L. The type I interferon system in the etiopathogenesis of autoimmune diseases. Ups J Med Sci 2011; 116: 227-237. doi: 10.3109/03009734.2011.624649.
Frieri M. Accelerated Atherosclerosis in Erythematosus: Role of Proinflammatory and Therapeutic Approaches. Curr Allergy Asthma Rep 2012; 12: 25-32. doi: 10.1007/s11882-011-0236-1.
Iwata Y, Furuichi K, Kaneko Sh, Wada T. The Role of Cytokine in the Lupus Nephritis. J Biomed Biotechnol 2011; 594809: 1-8. doi:10.1155/2011/594809.
Okamoto A, Fujio K, Okamura T and Yamamoto K. Regulatory T Cell- Associated Cytokines in Systemic Lupus Erythematosus. J Biomed Biotechnol 2011; 463412:1-10. doi: 10.1155/2011/463412.
Rezaei A, Ziaee V, Sharabian FT, Harsini S, Mahmoudi M, Soltani S, Sadr M, Moradinejad MH, Aghighi Y, Rezaei N. Lack of association between interleukin-10, transforming growth factor-beta gene polymorphisms and juvenile-onset systemic lupus erythematosus. Clin Rheumatol 2015; 34(6): 1059-64. doi: 10.1007/s10067-015-2877-2.
Deocharan B, Marambio P, Edelman M, Putterman C. Differential effects of interleukin-4 in peptide induced autoimmunity. Clin Immunol 2003; 108(2): 80-8.
Mahmoudi M, Tahghighi F, Ziaee V, Harsini S, Rezaei A, Soltani S, Sadr M, Moradinejad MH, Aghighi Y, Rezaei N. Interleukin-4 single nucleotide polymorphisms in juvenile systemic lupus erythematosus. Int J
Immunogenet 2014; 41(6): 512-7. doi: 10.1111/iji.12152.
Yu HH, Liu PH, Lin YC, Chen WJ, Lee JH, Wang LC, Yang YH, Chiang BL. Interleukin 4 and STAT6 gene polymorphisms are associated with systemic lupus erythematosus in Chinese patients. Lupus 2010; 19(10): 1219-28. doi: 10.1177/ 0961203310371152.
Wu MC, Huang CM, Tsai JJ, Chen HY, Tsai FJ. Polymorphisms of the interleukin-4 gene in chinese patients with systemic lupus erythematosus in Taiwan. Lupus 2003; 12(1): 21-5.
Sarra M, Monteleone G. Interleukin- 21: A new mediator of Inflammation in systemic lupus erythematosus. J Biomed Biotechnol 2010; 294582: 1- 6. doi: 10.1155/2010/294582.
Rajadhyaksha AG, Mehra S, Nadkar MY. Biologics in SLE: The Current Status. APRIL 2013; 61:262-267.
Jordan N, Lutalo PMK, D’Cruz DP. Novel therapeutic agents in clinical development for systemic lupus erythematosus. BMC Med 2013; 11: 1-11. doi: 10.1186/1741-7015-11-
120.
Vollenhoven RF, Parodis I, Levitsky A. Biologics in SLE: Towards new approaches. Best Practice & Research Clin Rheumatol 2013; 27: 341-349. doi: 10.1016/j.berh.2013. 07.006.
Stohl W. Therapeutic targeting of the BAFF/APRIL axis in systemic lupus erythematosus. Expert Opin Ther Targets 2014; 18(4): 473-89. doi: 10.1517/14728222.2014.888415.
Relle M and Schwarting A. Role of MHC-Linked Susceptibility Genes in the Pathogenesis of Human and Murine Lupus. Clin Develop Immunol 2012; 584374: 1-16. doi: 10.1155/2012/584374.
Tiffin N, Adeyemo A, Okpechi I. A diverse array of genetic factors contribute to the pathogenesis of Systemic Lupus Erythematosus. Orphanet Journal of Rare Diseases 2013; 8: 1-8. doi: 10.1186/1750- 1172-8-2.